Cytoreductive Surgery (CRS)

Cytoreductive Surgery (CRS) is an advanced surgical procedure used to treat cancers that have spread within the abdominal cavity, particularly to the peritoneal lining. The primary goal of CRS is to remove all visible cancer deposits from the abdomen to improve treatment outcomes and survival rates.

CRS is often combined with HIPEC (Hyperthermic Intraperitoneal Chemotherapy) for selected patients to target microscopic cancer cells and provide comprehensive cancer treatment.

Common Conditions Treated

Cytoreductive Surgery may be recommended for:

• Peritoneal Surface Malignancies
• Peritoneal Metastasis from Colon Cancer
• Appendiceal Cancer
• Ovarian Cancer Spread
• Pseudomyxoma Peritonei
• Selected Gastric Cancer Cases

Benefits of Cytoreductive Surgery

Patients may experience several advantages, including:

• Removal of visible cancer deposits
• Improved effectiveness of additional cancer therapies
• Better disease control within the abdomen
• Relief from abdominal symptoms and discomfort
• Improved survival outcomes in selected patients
• Personalized and targeted cancer treatment
• Enhanced quality of life after treatment

Symptoms That May Require Evaluation

You should consult a specialist if you experience:

• Persistent abdominal pain or bloating
• Abdominal swelling or fluid accumulation
• Changes in bowel habits
• Digestive discomfort or nausea
• Loss of appetite
• Unexplained weight loss
• Recurrent abdominal cancer symptoms

Treatment Approach

Every patient undergoes detailed evaluation including CT scans, PET scans, biopsy, and cancer staging before determining suitability for CRS. Treatment planning is highly individualized based on the extent of disease and overall patient health.

During surgery, visible cancer tissues are carefully removed from affected abdominal areas. In selected cases, CRS may be followed by HIPEC to destroy remaining microscopic cancer cells within the abdomen.

Benefits of Early Treatment

Timely intervention can help:

• Control cancer spread within the abdomen
• Improve treatment success rates
• Reduce complications from advanced disease
• Enhance recovery and long-term outcomes

Recovery and Follow-Up Care

Recovery after CRS depends on the extent of surgery and the patient’s overall health. Proper nutritional support, follow-up care, and monitoring are essential for successful recovery and ongoing cancer management.

The goal of Cytoreductive Surgery (CRS) is to provide advanced and effective treatment for abdominal cancers while improving disease control, survival outcomes, and patient quality of life.